(Q50435277)

English

Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions.

scientific article published in February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

cystic fibrosis

0 references

0 references

Sally J. Dawson

3

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

object named as

Ranjan Suri

2

0 references

author name string

Ghada Al-Malky

1

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

Tony Sirimanna

4

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

David Kemp

5

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

number of pages

11

1 reference

based on heuristic

inferred from page(s)

International Journal of Audiology

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

50

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

2

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

112-122

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

Current perspectives on inner ear toxicity

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Single or multiple daily doses of aminoglycosides: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Drug-induced ototoxicity.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Ototoxicity: understanding oxidative mechanisms

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Prevention of noise- and drug-induced hearing loss with D-methionine

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Sensorineural hearing loss in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Frequency of mitochondrial 12S ribosomal RNA variants in an adult cystic fibrosis population

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Ototoxicity of aminoglucoside antibiotics in long-term treatment for cystic fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

alpha-Tocopherol protective effects on gentamicin ototoxicity: an experimental study

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Mitochondrial gene mutation is a significant predisposing factor in aminoglycoside ototoxicity.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Aminoglycoside antibiotics

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

High-frequency (8 to 16 kHz) reference thresholds and intrasubject threshold variability relative to ototoxicity criteria using a Sennheiser HDA 200 earphone.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Pulmonary infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

[Prevalence of the A1555G mutation in the mitochondrial DNA in patients with cochlear or vestibular damage due to aminoglycoside-induced ototoxicity]

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Changes in otoacoustic emissions and high-frequency hearing thresholds in children and adolescents

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Audiologic testing and molecular analysis of 12S rRNA in patients receiving aminoglycosides

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Audiometer calibration: applying the earphone to the coupler.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Auditory monitoring in ototoxicity

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Aminoglycoside induced ototoxicity in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Identification of an overexpressed yeast gene which prevents aminoglycoside toxicity

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

A system for measuring distortion product otoacoustic emissions at ultra-sonic frequencies in rodents.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Effects of cis-platinum chemotherapy on otoacoustic emissions: the development of an objective screening protocol. Third place--Resident Clinical Science Award 1998.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Aminoglycoside-induced ototoxicity

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Aspirin to prevent gentamicin-induced hearing loss

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Protection from ototoxicity of intraperitoneal gentamicin in guinea pig.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Audiometer calibration: two neglected areas.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Aminoglycoside Prescribing and Surveillance in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

A survey of once-daily dosage tobramycin therapy in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Minimisation of aminoglycoside toxicity in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Aminoglycoside-induced ototoxicity

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Unilateral Vestibulotoxicity Due to Systemic Gentamicin Therapy

1 reference

https://api.crossref.org/works/10.3109%2F14992027.2010.524253

21 January 2018

Identifiers

10.3109/14992027.2010.524253

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21265638

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50435277&oldid=1774266224"